{
  "main_header": {
    "sid": 10039176,
    "name": "GPT Healthcare",
    "stock_name": "GPT Healthcare",
    "full_name": "GPT Healthcare Ltd",
    "name_url": "stocks-analysis/gpt-healthcare",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "156.80",
    "chg": -4,
    "chgp": "-2.49%",
    "dir": -1,
    "prev_price": "160.80",
    "mcapval": "1,286.62 Cr",
    "mcap": "Small Cap",
    "scripcode": 544131,
    "symbol": "GPTHEALTH",
    "ind_name": "Hospital",
    "ind_code": 94,
    "indexname": "India SENSEX",
    "isin": "INE486R01017",
    "curr_date": "Aug 12",
    "curr_time": "",
    "bse_nse_vol": "77.58 k",
    "exc_status": "Active",
    "traded_date": "Aug 12, 2026",
    "traded_date_str": "2026 08 12",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/gpt-healthcare-10039176-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "GPT Healthcare Ltd Valuation Shifts to Very Attractive Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gpt-healthcare-ltd-valuation-shifts-to-very-attractive-amid-market-volatility-4000126",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GPTHealthcareLt_valuationdot_4000126.png",
        "date": "2026-05-20 08:01:57",
        "description": "GPT Healthcare Ltd has witnessed a significant improvement in its valuation parameters, shifting from an attractive to a very attractive rating. This change reflects a more compelling price proposition for investors, supported by favourable price-to-earnings and price-to-book value ratios relative to its historical averages and peer group. Despite a modest market cap and micro-cap status, the hospital sector stock is showing signs of renewed investor interest amid improving fundamentals and valuation metrics."
      },
      {
        "title": "Are GPT Healthcare Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-gpt-healthcare-ltd-latest-results-good-or-bad-3999565",
        "imagepath": "",
        "date": "2026-05-19 19:21:33",
        "description": "The latest financial results for GPT Healthcare Ltd for the quarter ending March 2026 reflect a complex operational landscape. The company reported net sales of ₹126.37 crores, marking a sequential growth of 5.17% from the previous quarter and a year-on-year increase of 24.63%. This indicates strong revenue momentum, attributed to robust patient footfall and improved realisation per bed.\n\nHowever, the profitability metrics present a more nuanced picture. The net profit for the quarter surged to ₹14.57 crores, a significant increase of 55.50% from the previous quarter, but only a modest gain of 13.04% compared to the same quarter last year. The profit after tax (PAT) margin saw a decline to 11.53% from 12.71% year-on-year, highlighting rising cost pressures despite the strong revenue growth.\n\nOperating margins, excluding other income, were reported at 18.49%, down from 20.40% in the same quarter last year, i..."
      }
    ],
    "total": 15,
    "sid": "10039176",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/gpt-healthcare-10039176"
  },
  "announcements": [
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "07-Aug-2026",
      "details": "Please find enclosed voting results and scrutinizers report of the 37th Annual General Meeting of the Company held on August 6 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "07-Aug-2026",
      "details": "Please find enclosed herewith the Earnings Call Transcript on UFR for the Q1FY27.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
      "datetime": "06-Aug-2026",
      "details": "Please find enclosed proceedings/outcome of 37th Annual General Meeting of the Company held on August 6 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "GPT Healthcare Ltd has declared <strong>15%</strong> dividend, ex-date: 30 Jul 26",
          "dt": "2026-07-30",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

GPT Healthcare Ltd Valuation Shifts to Very Attractive Amid Market Volatility

2026-05-20 08:01:57

GPT Healthcare Ltd has witnessed a significant improvement in its valuation parameters, shifting from an attractive to a very attractive rating. This change reflects a more compelling price proposition for investors, supported by favourable price-to-earnings and price-to-book value ratios relative to its historical averages and peer group. Despite a modest market cap and micro-cap status, the hospital sector stock is showing signs of renewed investor interest amid improving fundamentals and valuation metrics.

Read More

Are GPT Healthcare Ltd latest results good or bad?

2026-05-19 19:21:33

The latest financial results for GPT Healthcare Ltd for the quarter ending March 2026 reflect a complex operational landscape. The company reported net sales of ₹126.37 crores, marking a sequential growth of 5.17% from the previous quarter and a year-on-year increase of 24.63%. This indicates strong revenue momentum, attributed to robust patient footfall and improved realisation per bed. However, the profitability metrics present a more nuanced picture. The net profit for the quarter surged to ₹14.57 crores, a significant increase of 55.50% from the previous quarter, but only a modest gain of 13.04% compared to the same quarter last year. The profit after tax (PAT) margin saw a decline to 11.53% from 12.71% year-on-year, highlighting rising cost pressures despite the strong revenue growth. Operating margins, excluding other income, were reported at 18.49%, down from 20.40% in the same quarter last year, i...

Read More

View All News